(Q51743500)

English

Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the Pan-American Collaborative Retina Study Gro

scientific article published on 31 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the Pan-American Collaborative Retina Study Gro (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

1 reference

based on heuristic

inferred from title

neovascularization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

1

object named as

Lihteh Wu

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

author name string

J Fernando Arevalo

2

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

Maria H Berrocal

4

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

Juan Sanchez

5

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

Teodoro Evans

6

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

Pan-American Collaborative Retina Study Group (PACORES)

7

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

publication date

31 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

Japanese Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

53

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

2

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

125-130

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

https://scigraph.springernature.com/pub.10.1007/s10384-008-0622-y

0 references

Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10384-008-0622-Y

21 January 2018

Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-008-0622-Y

21 January 2018

Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1007%2FS10384-008-0622-Y

21 January 2018

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factors and angiogenesis in eye disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safe and effective

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardized visual acuity results associated with primary versus secondary bevacizumab (avastin) treatment for choroidal neovascularization in age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of choroidal neovascularization using intravitreal bevacizumab.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegaptanib for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19333696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10384-008-0622-Y

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/19333696

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51743500&oldid=2158048106"